CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 195 filers reported holding CORCEPT THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is 1.06 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $126,117 | +22.4% | 4,629 | 0.0% | 0.01% | +40.0% |
| Q2 2023 | $102,995 | -3.1% | 4,629 | -5.7% | 0.01% | 0.0% |
| Q1 2023 | $106,329 | -2.8% | 4,909 | -8.9% | 0.01% | 0.0% |
| Q4 2022 | $109,390 | -20.8% | 5,386 | 0.0% | 0.01% | -28.6% |
| Q3 2022 | $138,097 | +7.8% | 5,386 | 0.0% | 0.01% | +16.7% |
| Q2 2022 | $128,079 | +5.6% | 5,386 | 0.0% | 0.01% | +50.0% |
| Q1 2022 | $121,293 | -76.4% | 5,386 | -79.3% | 0.00% | -42.9% |
| Q4 2021 | $514,127 | +0.6% | 25,966 | 0.0% | 0.01% | 0.0% |
| Q3 2021 | $511,011 | -18.0% | 25,966 | -8.3% | 0.01% | -22.2% |
| Q2 2021 | $623,172 | -1.2% | 28,326 | +6.8% | 0.01% | 0.0% |
| Q1 2021 | $630,982 | -12.4% | 26,523 | -3.6% | 0.01% | -18.2% |
| Q4 2020 | $719,897 | +36.0% | 27,519 | -9.5% | 0.01% | +22.2% |
| Q3 2020 | $529,478 | +3.5% | 30,421 | 0.0% | 0.01% | 0.0% |
| Q2 2020 | $511,681 | +41.5% | 30,421 | 0.0% | 0.01% | +12.5% |
| Q1 2020 | $361,706 | +0.2% | 30,421 | +1.9% | 0.01% | +33.3% |
| Q4 2019 | $361,125 | -17.5% | 29,845 | -3.7% | 0.01% | -14.3% |
| Q3 2019 | $437,860 | +26.8% | 30,977 | 0.0% | 0.01% | +16.7% |
| Q2 2019 | $345,394 | -5.0% | 30,977 | 0.0% | 0.01% | -14.3% |
| Q1 2019 | $363,670 | -12.1% | 30,977 | 0.0% | 0.01% | -12.5% |
| Q4 2018 | $413,853 | -4.7% | 30,977 | 0.0% | 0.01% | 0.0% |
| Q3 2018 | $434,298 | -99.9% | 30,977 | 0.0% | 0.01% | 0.0% |
| Q2 2018 | $486,958,000 | -2.5% | 30,977 | +2.0% | 0.01% | +14.3% |
| Q1 2018 | $499,587,000 | +92587.8% | 30,370 | +1.7% | 0.01% | 0.0% |
| Q4 2017 | $539,000 | -55.7% | 29,856 | -52.6% | 0.01% | -12.5% |
| Q3 2017 | $1,216,000 | +63.7% | 62,997 | 0.0% | 0.01% | +60.0% |
| Q2 2017 | $743,000 | +20.4% | 62,997 | +11.9% | 0.01% | +25.0% |
| Q1 2017 | $617,000 | +59.4% | 56,303 | +5.6% | 0.00% | +33.3% |
| Q4 2016 | $387,000 | +4.0% | 53,311 | -6.9% | 0.00% | 0.0% |
| Q3 2016 | $372,000 | +19.2% | 57,244 | +0.1% | 0.00% | +50.0% |
| Q2 2016 | $312,000 | +36.8% | 57,179 | +17.2% | 0.00% | 0.0% |
| Q1 2016 | $228,000 | +12.9% | 48,807 | +20.2% | 0.00% | 0.0% |
| Q4 2015 | $202,000 | +32.0% | 40,604 | 0.0% | 0.00% | +100.0% |
| Q3 2015 | $153,000 | -34.1% | 40,604 | +5.1% | 0.00% | -50.0% |
| Q2 2015 | $232,000 | -5.7% | 38,629 | -12.2% | 0.00% | 0.0% |
| Q1 2015 | $246,000 | +19.4% | 44,002 | -6.7% | 0.00% | +100.0% |
| Q1 2014 | $206,000 | – | 47,179 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INGALLS & SNYDER LLC | 6,911,376 | $155,644,000 | 6.95% |
| Parallel Advisors, LLC | 1,944,319 | $47,014,000 | 1.86% |
| TANAKA CAPITAL MANAGEMENT INC | 39,289 | $885,000 | 1.79% |
| S&T BANK/PA | 508,546 | $11,452,000 | 1.73% |
| Bridge City Capital, LLC | 83,967 | $1,891,000 | 0.88% |
| Birchview Capital, LP | 50,000 | $1,126,000 | 0.81% |
| Quantedge Capital Pte Ltd | 113,012 | $2,545,000 | 0.75% |
| FAS Wealth Partners, Inc. | 289,625 | $6,522,000 | 0.61% |
| AJ WEALTH STRATEGIES, LLC | 396,029 | $8,919,000 | 0.44% |
| TRUSTCORE FINANCIAL SERVICES, LLC | 208,806 | $4,702,000 | 0.41% |